News Articles Tagged: Cancer Targets

Vanillin and Cancer Receptors: A Molecular Dialogue for Therapeutic Intervention

An in-depth look at the specific molecular targets of vanillin within cancer cells, including TRPV1, CK2α, CAMK4, and MARK4, and their implications for cancer therapy.

In Silico Insights: Targeting AKT and BRAF with 2,2'-Bipyridine Derivatives

Explore the computational approach of using molecular docking to understand how 2,2'-Bipyridine derivatives interact with key cancer targets like AKT and BRAF.

Exploring 25-Hydroxycholesterol: Mechanism and Application in Cancer Research

NINGBO INNO PHARMCHEM CO.,LTD. summarizes the scientific findings on 25-hydroxycholesterol, emphasizing its apoptosis-inducing mechanisms and therapeutic implications in cancer.

The Intricate Link Between L-Asparagine and Cancer: A Metabolic Perspective

Gain a deeper understanding of how L-Asparagine metabolism is altered in various cancers and the implications for therapeutic strategies. Learn about resistance mechanisms and future directions. NINGBO INNO PHARMCHEM CO.,LTD. reports.

The PI3K/Akt Pathway: A Key Target in Cancer Therapy with Ipatasertib

Explore the critical role of the PI3K/Akt pathway in cancer and how Ipatasertib, a selective pan-Akt inhibitor, targets this pathway for therapeutic benefit.

The Role of Serine Proteases in Cancer: From Biomarkers to Therapeutic Targets

Delve into the intricate involvement of serine proteases, like trypsin and chymotrypsin, in cancer development, progression, and their potential as biomarkers and therapeutic targets, a key area of focus for NINGBO INNO PHARMCHEM.